Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the Tirzepatide treatment on coronary atherosclerosis progression: The (T-PLAQUE) randomized-controlled trial design: tirzepatide and plaque.
tirzepatide 對冠狀動脈動脈粥樣硬化進展的影響:使用 MDCT 的理由與設計:Tirzepatide 對冠狀動脈動脈粥樣硬化進展的隨機對照試驗設計:tirzepatide 與斑塊。
Am Heart J 2024-08-26
Liraglutide treatment is associated with progression of coronary artery fibrous plaque: a prospective 1-year follow-up study in asymptomatic patients with type 2 diabetes.
利拉魯肽治療與冠狀動脈纖維斑塊進展相關:對於2型糖尿病無症狀患者的前瞻性1年追蹤研究。
BMC Cardiovasc Disord 2023-05-03
A Phase 1 Multiple Dose Study of Tirzepatide in Chinese Patients with Type 2 Diabetes.
一項關於 Tirzepatide 在中國第二型糖尿病患者中的多劑量 Phase 1 研究。
Adv Ther 2023-08-22
Is tirzepatide 15 mg the preferred treatment strategy for type 2 diabetes? A meta-analysis and trial-sequence-analysis.
Tirzepatide 15 毫克是否是第二型糖尿病的首選治療策略?一項荟萃分析和試驗序列分析。
Eur Rev Med Pharmacol Sci 2023-10-18
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.
Tirzepatide 和 dulaglutide 在患有第二型糖尿病和動脈粥樣硬化心血管疾病參與者中對主要不良心血管事件的比較:SURPASS-CVOT 設計和基線特徵。
Am Heart J 2023-12-20
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis.
Tirzepatide降低預測的動脈粥樣硬化心血管疾病風險,並改善肥胖或超重成年人的心臟代謝風險因子:SURMOUNT-1事後分析。
Diabetes Obes Metab 2024-04-02
Tirzepatide: A novel cardiovascular protective agent in type 2 diabetes mellitus and obesity.
Tirzepatide:一種新型心血管保護劑在第2型糖尿病和肥胖症中。
Curr Probl Cardiol 2024-04-02
Longitudinal assessment of coronary plaque regression related to sodium-glucose cotransporter-2 inhibitor using coronary computed tomography angiography.
使用冠狀動脈電腦斷層血管造影進行與鈉-葡萄糖共轉運蛋白-2抑制劑相關的冠狀動脈斑塊回歸的縱向評估。
Cardiovasc Diabetol 2024-07-22
Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes.
Tirzepatide 或 GLP-1 受體激動劑在 2 型糖尿病患者中的臨床結果。
JAMA Netw Open 2024-08-12
Tirzepatide's innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health.
Tirzepatide 在 2 型糖尿病管理中的創新應用及其在心血管健康中的未來前景。
Front Pharmacol 2024-09-12